Newsquawk Logo

Pennsylvania jury finds Johnson & Johnson (JNJ) liable for woman's ovarian cancer

The Pennsylvania jury's decision to hold Johnson & Johnson liable in this case could have significant implications for the company, potentially leading to sizable financial liabilities and affecting investor sentiment.

Newsquawk StaffPublished On the live feed at — 2 more headlines followed before this page went public
Newsquawk headlinesUTC

FDA publishes complete response letter for Disc Medicine's (IRON) NDA for bitopertin; have completed review of this application, as amended, and have determined that we cannot approve this application in its present form

US nuclear regulator issues permit for X-energy high assay low enriched uranium fuel (Haleu) plant for planned high-tech reactors

Pennsylvania jury finds Johnson & Johnson (JNJ) liable for woman's ovarian cancer

CRUDE WRAP: WTI (H6) SETTLES USD 0.05 HIGHER AT USD 62.89/BBL; BRENT (J6) SETTLES USD 0.23 HIGHER AT USD 67.75/BBL

Meta (META) says it won't chop the bottom 5% performers this year, Business Insider reports

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free
Free. No signup, no card.
Context

This ruling may prompt discussions around product safety and regulatory scrutiny, which could weigh on stock performance not only for JNJ but also for peers in the pharmaceutical sector. Monitoring any further developments, including appeals or additional lawsuits, will be crucial for understanding the long-term impact on the stock and sector valuations.

Related headlines

The whole workspace, free to try.

Try it free
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.